Lenalidomide Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
ZR2 Sequential Immunochemotherapy for Newly Treated MCL
Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
Zhejiang Cancer Hospital48 enrolled1 locationNCT05992597
Recruiting
Phase 2
Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
Peripheral T Cell LymphomaLenalidomideCHOP
Second Affiliated Hospital, School of Medicine, Zhejiang University289 enrolled1 locationNCT04922567